Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Chlipala

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Toxicologic Pathology|January 20, 2025
Myelin Methods: A Mini-ReviewBrad Bolon, Amber Moser, Elizabeth Chlipala
Journal of Histotechnology|August 30, 2024
What will it take for histologists to be recognized under CLIA?Elizabeth Chlipala, Tim Morken, Clare Thornton, et al.
Journal of Histotechnology|November 1, 2022
Guide for collecting and reporting metadata on protocol variables and parameters from slide-based histotechnology assays to enhance reproducibilityLuis Chiriboga, Gayle M Callis, Yongfu Wang, et al.
Experimental and Molecular Pathology|February 7, 2006
Different susceptibilities of PECAM-deficient mouse strains to spontaneous idiopathic pneumonitisAlan R Schenkel, Tina W Chew, Elizabeth Chlipala, et al.
Journal of Histotechnology|June 23, 2025
Utilizing image analysis by optical density to evaluate changes in hematoxylin and eosin staining quality after reagent overuseHannah M Benton, Mark Butters, Miles Brous, et al.
Journal of Histotechnology|January 24, 2020
Optical density-based image analysis method for the evaluation of hematoxylin and eosin staining precisionElizabeth Chlipala, Christine M Bendzinski, Kevin Chu, et al.
Toxicologic Pathology|June 23, 2012
Scientific and Regulatory Policy Committee (SRPC) paper: validation of digital pathology systems in the regulated nonclinical environmentRichard E Long, Adam Smith, Sam V Machotka, et al.
Anticancer Research|December 25, 2009
ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor modelsRichard Woessner, Brian Tunquist, Christine Lemieux, et al.
Journal of Histotechnology|November 13, 2023
Immunohistochemistry as an assayMichelle Bell, Luis Chiriboga, Elizabeth Chlipala, et al.
Plos One|November 27, 2019
Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primatesJeff L Ellsworth, Jacinthe Gingras, Laura J Smith, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Toxicologic Pathology|January 20, 2025
Myelin Methods: A Mini-ReviewBrad Bolon, Amber Moser, Elizabeth Chlipala
Journal of Histotechnology|August 30, 2024
What will it take for histologists to be recognized under CLIA?Elizabeth Chlipala, Tim Morken, Clare Thornton, et al.
Journal of Histotechnology|November 1, 2022
Guide for collecting and reporting metadata on protocol variables and parameters from slide-based histotechnology assays to enhance reproducibilityLuis Chiriboga, Gayle M Callis, Yongfu Wang, et al.
Experimental and Molecular Pathology|February 7, 2006
Different susceptibilities of PECAM-deficient mouse strains to spontaneous idiopathic pneumonitisAlan R Schenkel, Tina W Chew, Elizabeth Chlipala, et al.
Journal of Histotechnology|June 23, 2025
Utilizing image analysis by optical density to evaluate changes in hematoxylin and eosin staining quality after reagent overuseHannah M Benton, Mark Butters, Miles Brous, et al.
Journal of Histotechnology|January 24, 2020
Optical density-based image analysis method for the evaluation of hematoxylin and eosin staining precisionElizabeth Chlipala, Christine M Bendzinski, Kevin Chu, et al.
Toxicologic Pathology|June 23, 2012
Scientific and Regulatory Policy Committee (SRPC) paper: validation of digital pathology systems in the regulated nonclinical environmentRichard E Long, Adam Smith, Sam V Machotka, et al.
Anticancer Research|December 25, 2009
ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor modelsRichard Woessner, Brian Tunquist, Christine Lemieux, et al.
Journal of Histotechnology|November 13, 2023
Immunohistochemistry as an assayMichelle Bell, Luis Chiriboga, Elizabeth Chlipala, et al.
Plos One|November 27, 2019
Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primatesJeff L Ellsworth, Jacinthe Gingras, Laura J Smith, et al.
Pageof 2